Detalles de la búsqueda
1.
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.
Haematologica
; 103(3): 456-465, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29242298
2.
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.
Blood
; 124(8): 1304-11, 2014 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24923295
3.
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
Blood
; 122(10): 1761-9, 2013 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23878140
4.
Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study.
Med Microbiol Immunol
; 204(5): 585-92, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25573349
5.
Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study.
Health Qual Life Outcomes
; 13: 28, 2015 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888906
6.
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
Blood
; 120(2): 395-403, 2012 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22649106
7.
Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction.
Haematologica
; 104(11): e510-e513, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30948486
8.
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.
Haematologica
; 99(8): 1317-25, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24816240
9.
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Leukemia
; 38(1): 45-57, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38017103
10.
RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
Haematologica
; 97(12): 1909-15, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22689681
11.
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
Ann Hematol
; 91(7): 1051-63, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22362118
12.
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Lancet
; 376(9757): 2000-8, 2010 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21131036
13.
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Blood
; 112(10): 4193-201, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18716133
14.
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia.
Leukemia
; 34(10): 2621-2634, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32358566
15.
The clinical mutatome of core binding factor leukemia.
Leukemia
; 34(6): 1553-1562, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31896782
16.
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia.
Sci Rep
; 8(1): 11293, 2018 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30050054
17.
Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia.
Diagn Microbiol Infect Dis
; 85(4): 413-5, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27220608
18.
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Nat Commun
; 7: 11733, 2016 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27252013
19.
6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
J Clin Oncol
; 21(24): 4496-504, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14673036
20.
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
J Clin Oncol
; 21(2): 256-65, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12525517